SCHEMBL4608740

SCHEMBL4608740

CC(C)(C)OC(=O)N(c1ccccc1)C(C(=O)O)c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.36
ESR2 Q92731 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CES2 O00748 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8724217 0.92 NR1H2 (0.39) L3MBTL1ALDH1A1LMNAKMT2ATDP1
SCHEMBL15723420 0.80 SRC (0.36) ESR1ESR2L3MBTL1ALDH1A1
SCHEMBL20556352 0.80 SRC (0.36) ESR1ESR2L3MBTL1ALDH1A1
SCHEMBL20917440 0.77 CTSK (0.41) L3MBTL1LMNANR1H2NR1H3
SCHEMBL642839 0.77 SMN1; SMN2 (0.41) ALDH1A1LMNAKMT2ATDP1TP53
SCHEMBL9382586 0.77 SMN1; SMN2 (0.41) ALDH1A1LMNAKMT2ATDP1TP53
SCHEMBL6257491 0.77 SMN1; SMN2 (0.38) L3MBTL1ALDH1A1LMNAKMT2ATDP1
SCHEMBL6257488 0.77 SMN1; SMN2 (0.38) L3MBTL1ALDH1A1LMNAKMT2ATDP1
SCHEMBL9407522 0.75 SMN1; SMN2 (0.42) L3MBTL1ALDH1A1LMNAKMT2ATDP1
SCHEMBL994016 0.74 MMP13 (0.41) L3MBTL1GAANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907352-A2 NOVEL DERIVATIVES OF AMINO ACIDS FOR TREATMENT OF OBESITY AND RELATED DISORDERS Bexel Pharmaceuticals Inc (US) 2008-04-09 EP disclosed
WO-2007005774-A2 NOVEL DERIVATIVES OF AMINO ACIDS FOR TREATMENT OF OBESITY AND RELATED DISORDERS BEXEL PHARMACEUTICALS, INC. (US) 2007-01-11 WO disclosed